Oruka Therapeutics, Inc. (ORKA : NASDAQ)
Common Stock
$82.11
USD
+4.83 (6.25%)
Last updated: 2026-10-09
Follow ORKA
ORKA
Oruka Therapeutics, Inc.
WealthAwesomePerformance
1 Day
+6.25%
1 Week
-2.85%
1 Month
-10.26%
YTD
+15.84%
Key Statistics
Market Cap
$5.44B
52W High
$115.52
52W Low
$24.88
P/E Ratio
-
50 Day MA
$94.66
200 Day MA
$65.19
Beta
-0.11
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/9/2026 | $77.24 | $82.24 | $77.00 | $82.11 | $82.11 | 1,206,700 |
| 10/8/2026 | $78.47 | $80.19 | $75.83 | $77.28 | $77.28 | 1,224,945 |
| 10/7/2026 | $79.01 | $81.39 | $78.52 | $79.50 | $79.50 | 809,885 |
| 10/6/2026 | $84.94 | $84.94 | $77.78 | $80.18 | $80.18 | 1,122,000 |
| 10/5/2026 | $84.52 | $85.22 | $81.83 | $84.38 | $84.38 | 629,588 |
| 10/2/2026 | $84.81 | $86.00 | $83.33 | $84.52 | $84.52 | 581,500 |
| 10/1/2026 | $82.85 | $85.00 | $82.50 | $83.42 | $83.42 | 921,019 |
| 9/30/2026 | $83.33 | $86.51 | $82.27 | $83.29 | $83.29 | 1,534,596 |
| 9/29/2026 | $83.32 | $84.67 | $81.11 | $82.15 | $82.15 | 1,363,056 |
| 9/28/2026 | $83.94 | $85.95 | $83.22 | $84.19 | $84.19 | 923,245 |
Analyst Price Targets
Based on 13 analysts covering ORKA · as of Oct 5, 2026
Wall Street analysts forecast ORKA stock price to rise 88.8% over the next 12 months.
Consensus
Strong Buy4.85 / 5.00
Avg. Target
US$155.00
+88.8% Upside
Current Price
US$82.11
Last close
Analyst Breakdown (13 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ORKA's historical volatility
30-Day Vol
45.8%
Annualized
90-Day Vol
61.3%
Annualized
Trend (90d)
-4.7%
Annualized drift
90d Mean
US$80.73
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$81.65 | US$69.71 – US$95.63 |
| 60 trading days | US$81.19 | US$64.93 – US$101.53 |
| 90 trading days | US$80.73 | US$61.40 – US$106.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-154.94M
- Profit Margin
- 0.00%
- ROE (TTM)
- -18.23%
- EPS (Diluted)
- -2.04
- Book Value
- 18.20
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About ORKA.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DFLI | Dragonfly Energy Holdings Corp. | $3.72 | +658.88% |
| WFF | WF Holding Limited Ordinary Shares | $12.29 | +499.51% |
| ILLR | Triller Group Inc. Common Stock | $0.08 | +100.97% |
| JZ | Jianzhi Education Technology Group Company Limited American Depositary Shares | $1.28 | +53.48% |
| ZYBT | Zhengye Biotechnology Holding Limited Ordinary Shares | $1.73 | +50.45% |
| VEEA | Veea Inc. | $5.70 | +47.29% |
| QETA | Quetta Acquisition Corporation Common Stock | $16.41 | +41.47% |
| PDSB | PDS Biotechnology Corp | $1.38 | +35.29% |
ORKA.US news timeline
1 article covering ORKA.US, most recent first
Latest